Hepcidin
Hepcidin is a protein pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
98 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anemia | D000740 | HP_0001903 | D64.9 | 3 | 3 | 2 | 6 | 21 | 34 |
| Iron deficiencies | D000090463 | — | — | — | 1 | — | 3 | 26 | 30 |
| Iron-deficiency anemia | D018798 | HP_0001891 | D50 | — | 1 | — | 3 | 21 | 25 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | 1 | 5 | 6 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.9 | 1 | 2 | — | 1 | 2 | 5 |
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | 2 | 1 | 3 |
| Colorectal neoplasms | D015179 | — | — | — | — | — | 2 | — | 2 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | — | — | — | 1 | 1 | 2 |
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | — | — | 1 | 1 | 2 |
| Deficiency diseases | D003677 | EFO_1001067 | E63 | — | — | — | 2 | — | 2 |
Show 6 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Polycythemia vera | D011087 | — | D45 | — | 2 | 2 | — | — | 4 |
| Polycythemia | D011086 | EFO_0005804 | D75.1 | — | 2 | 2 | — | — | 4 |
| Critical care | D003422 | — | — | — | — | 1 | — | 1 | 2 |
| Essential thrombocythemia | D013920 | — | D47.3 | — | — | 1 | — | — | 1 |
| Primary myelofibrosis | D055728 | — | D47.4 | — | — | 1 | — | — | 1 |
| Thrombocytosis | D013922 | HP_0001894 | D75.83 | — | — | 1 | — | — | 1 |
| Postoperative hemorrhage | D019106 | — | — | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Chronic renal insufficiency | D051436 | — | N18 | 3 | 4 | — | — | 2 | 7 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 3 | 4 | — | — | 2 | 7 |
| Iron overload | D019190 | — | — | — | 2 | — | — | 4 | 6 |
| Chronic disease | D002908 | — | — | 2 | 1 | — | — | 2 | 5 |
| Thalassemia | D013789 | EFO_1001996 | D56 | — | 2 | — | — | 2 | 4 |
| Hemochromatosis | D006432 | EFO_1000642 | E83.11 | — | 2 | — | — | 1 | 3 |
| Hemosiderosis | D006486 | — | — | — | 2 | — | — | 1 | 3 |
| Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | — | 2 | — | — | 1 | 3 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | 1 | 2 |
| Disease | D004194 | EFO_0000408 | R69 | — | 1 | — | — | — | 1 |
Show 3 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | 1 | — | — | — | 9 | 10 |
| Healthy volunteers/patients | — | — | — | 1 | — | — | — | 1 | 2 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Iron metabolism disorders | D019189 | — | E83.1 | — | — | — | — | 6 | 6 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 4 | 4 |
| Sepsis | D018805 | HP_0100806 | A41.9 | — | — | — | — | 4 | 4 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | — | — | — | — | 3 | 3 |
| Hepatitis c | D006526 | — | B19.2 | — | — | — | — | 2 | 2 |
| Hepatitis | D006505 | HP_0012115 | K75.9 | — | — | — | — | 2 | 2 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | — | — | — | — | 2 | 2 |
| Fibrosis | D005355 | — | — | — | — | — | — | 2 | 2 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | — | — | — | 2 | 2 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 2 | 2 |
Show 41 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Hepcidin |
| INN | hepcidin |
| Description | Hepcidin is a protein that in humans is encoded by the HAMP gene. Hepcidin is a key regulator of the entry of iron into the circulation in mammals.
|
| Classification | Protein |
| Drug class | natural antibiotics (undefined group) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | >3H0T:A|Fab fragment, Light chain
NFMLTQPHSVSESPGKTVTISCTRSSGSIASYYVQWYQQRPGSSPTTVIYEDSQRPSGVPDRFSGSIDSSSNSASLTISG
LKTEDEADYYCQSYDSSNVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVK
AGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS
>3H0T:B|Fab fragment, Heavy chain
QVQLQQSGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGRTYYRSKWFNDYAVSVQSRITINPDTSKN
QFSLQLNSVTPEDTAVYYCARGIVFSYAMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVT
VSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCAADEVDHHHHHH |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 16,761 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use